Swine Interferon-Inducible Transmembrane Proteins Potently Inhibit African Swine Fever Virus Replication.
African swine fever virus
antiviral effect
interferon-inducible transmembrane protein
restriction
swine
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
12
2021
accepted:
04
03
2022
entrez:
11
4
2022
pubmed:
12
4
2022
medline:
13
4
2022
Statut:
epublish
Résumé
African swine fever virus (ASFV) causes an acute, hemorrhagic, and highly contagious disease in domestic swine, leading to significant economic losses to the global porcine industry. Restriction factors of innate immunity play a critical in host antiviral action. However, function of swine restriction factors of innate immunity on ASFV has been seldomly investigated. In this study, we determined five homologues of swine interferon-induced transmembrane proteins (SwIFITM [named SwIFITM1a, -1b, -2, -3, and -5]), and we found that they all exhibit potent antiviral activity against ASFV. Expression profile analysis indicated that these SwIFITMs are constitutively expressed in most porcine tissues. Whether infected with ASFV or treated with swine interferon, the expression levels of SwIFITMs were induced
Identifiants
pubmed: 35401540
doi: 10.3389/fimmu.2022.827709
pmc: PMC8989734
doi:
Substances chimiques
Antiviral Agents
0
Membrane Proteins
0
Interferons
9008-11-1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
827709Informations de copyright
Copyright © 2022 Cai, Zheng, Cheng, Zhong, Shao, Zheng, Lai, Ou, Xu, Zhou, Lu and Zhang.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Am J Vet Res. 1960 Jan;21:104-8
pubmed: 14420403
J Virol. 2013 Dec;87(23):12957-66
pubmed: 24067955
Annu Rev Virol. 2014 Nov 1;1:261-283
pubmed: 25599080
Front Vet Sci. 2020 May 13;7:215
pubmed: 32478103
Fish Shellfish Immunol. 2013 Sep;35(3):918-26
pubmed: 23850425
Front Immunol. 2018 Feb 16;9:228
pubmed: 29503647
Virus Res. 2013 Apr;173(1):87-100
pubmed: 23165138
Cell. 2009 Dec 24;139(7):1243-54
pubmed: 20064371
Viruses. 2019 Jan 30;11(2):
pubmed: 30704088
PLoS Pathog. 2011 Jan 06;7(1):e1001258
pubmed: 21253575
J Gen Virol. 2018 May;99(5):613-614
pubmed: 29565243
J Virol. 2011 Mar;85(5):2126-37
pubmed: 21177806
J Biol Chem. 2014 Apr 25;289(17):11986-11992
pubmed: 24627473
Viruses. 2015 Jun 12;7(6):3035-52
pubmed: 26075508
Front Microbiol. 2019 May 16;10:1097
pubmed: 31156602
Science. 2014 Jan 3;343(6166):84-87
pubmed: 24336571
J Infect Dis. 2015 Oct 1;212 Suppl 2:S210-8
pubmed: 26034199
J Virol. 2020 Nov 23;94(24):
pubmed: 32999030
Elife. 2013 Feb 19;2:e00333
pubmed: 23550179
PLoS Pathog. 2011 Oct;7(10):e1002337
pubmed: 22046135
Antiviral Res. 2019 May;165:34-41
pubmed: 30836106
PLoS One. 2012;7(3):e34508
pubmed: 22479637
Viruses. 2020 Jul 28;12(8):
pubmed: 32731642
PLoS Pathog. 2014 Apr 03;10(4):e1004048
pubmed: 24699674
Cell Rep. 2013 Nov 27;5(4):895-908
pubmed: 24268777
J Biol Chem. 2013 Jun 14;288(24):17261-71
pubmed: 23649619
Intractable Rare Dis Res. 2021 Aug;10(3):165-172
pubmed: 34466338
J Biol Chem. 2015 Oct 23;290(43):25946-59
pubmed: 26354436
PLoS Pathog. 2017 Sep 28;13(9):e1006610
pubmed: 28957419
PLoS One. 2012;7(2):e31961
pubmed: 22363774
J Virol. 2015 Jan;89(1):863-9
pubmed: 25320322
Cell Microbiol. 2014 Jul;16(7):1080-93
pubmed: 24521078
Virology. 2015 Jan 1;474:10-8
pubmed: 25463599
J Virol. 2017 May 12;91(11):
pubmed: 28331099
Nat Rev Immunol. 2013 Jan;13(1):46-57
pubmed: 23237964
PLoS One. 2016 Apr 26;11(4):e0154366
pubmed: 27116236
J Virol. 2013 Jul;87(14):7837-52
pubmed: 23658454
Int J Mol Sci. 2019 Aug 08;20(16):
pubmed: 31398796